MONTREAL, April 7 /PRNewswire/ - Haemacure Corporation announces the closing of the purchase by Angiotech Pharmaceuticals,Inc. of substantially all its assets, consisting mainly of its two product candidates and the associated intellectual property and manufacturing plant. The transaction was entered into with authorization from competent courts in Canada
As previously announced, Haemacure filed last January a notice of intention to make a proposal to its creditors in Canada and sought court protection in the United States. Haemacure intends to make such proposal no later than April 19, 2010, as authorized by the court. The recovery of any sums by creditors and shareholders is uncertain.
SOURCE HAEMACURE CORPORATION
Subscribe to our Free Newsletters!
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...
Bile duct cancer occurs either within the liver or the point where the bile ducts emerge from the ...
Xeroderma pigmentosum is a rare inherited condition marked by extreme sensitivity to sunlight and ...View All